Shalby Ltd.

View in App
308.00 +1.30 ▲0.4%

01 December 2023, 04:01:00 PM
Volume: 25,283

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.shalby.org
Market Cap 3,320.76 Cr.
Enterprise Value(EV) 3,435.15 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 7.18 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 42.80 Trailing Twelve Months Ending 2023-09
Industry PE 63.34 Trailing Twelve Months Ending 2023-09
Book Value / Share 89.30 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.44 Calculated using Price: 307.45
Dividend Yield 0.39 Period Ending 2023-03
No. of Shares Subscribed 10.80 Cr. 108,009,770 Shares
FaceValue 10
About Shalby Ltd.
The company is one of the leading multi-specialty chains of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

Shalby Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Shalby Ltd. Performance

View details >>
1 Day
+0.42%
1 Week
-0.13%
1 Month
+17.11%
3 Month
+36.19%
6 Month
+122.46%
1 Year
+105.95%
2 Year
+124.33%
5 Year
+95.99%
10 Year

Shalby Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 15.92 19.50 12.60 7.81 4.13 3.49 5.19 6.31 7.51
Return on Capital Employed (%) 21.84 13.34 12.21 9.15 6.94 7.49 6.85 9.08 10.72
Return on Assets (%) 8.64 8.49 4.61 4.42 3.12 2.72 4.05 4.60 5.06

Shalby Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 168 205 251 751 780 799 835 876 928 964
Non Curr. Liab. 90 207 291 140 130 144 150 234 269 159
Curr. Liab. 90 92 199 138 88 83 82 172 194 193
Minority Int. 2 0 -1 0 0 0 0 0 0 0
Equity & Liab. 351 504 741 1,030 998 1,027 1,066 1,282 1,391 1,316
Non Curr. Assets 289 440 582 794 801 793 795 833 874 760
Curr. Assets 63 64 159 236 197 234 271 442 517 556
Misc. Exp. not W/O
Total Assets 351 504 741 1,030 998 1,027 1,066 1,282 1,391 1,316

Shalby Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 275 290 324 378 462 487 431 699 805 875
Other Income 2 2 7 10 9 17 9 12 23 23
Total Income 278 293 331 388 472 504 440 711 827 898
Total Expenditure -208 -235 -252 -299 -379 -404 -344 -577 -667 -719
PBIDT 70 58 78 89 93 100 96 134 161 179
Interest -5 -10 -11 -12 -9 -7 -5 -8 -11 -11
Depreciation -21 -11 -17 -23 -33 -36 -37 -43 -48 -49
Taxation -18 0 -22 -15 -19 -29 -13 -25 -34 -41
Exceptional Items -4
PAT 25 36 29 39 32 28 42 54 68 78
Minority Interest 1 1 1 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 26 38 30 39 32 28 42 54 68 78
Adjusted EPS 7 4 3 4 3 3 4 5 6 7

Shalby Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 123 5 60 14 43 55 79 19 68
Cash Fr. Inv. -26 -62 -98 -153 -237 1 -31 -51 -60 -61
Cash Fr. Finan. 24 -39 75 96 222 -51 -22 -30 90 -50
Net Change 3 22 -19 3 0 -6 3 -2 49 -43
Cash & Cash Eqvt 6 27 9 12 12 5 8 6 56 12

Shalby Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 74.02 74.02 74.02 74.04 74.04 74.12 74.12 74.12 74.12
Public 25.98 25.98 25.98 25.97 25.97 25.88 25.88 25.88 25.88
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Shalby Ltd. Announcements

View details >>
Fri, 01 Dec 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Exercise of Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
Fri, 01 Dec 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Shalby Management is doing a one-to-one online meeting with Investor on December 6 2023
Thu, 30 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Shalby Management is doing a one-to-one in-person investors meeting on December 5 2023 in Singapore.

Shalby Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Shalby Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Shalby Ltd. FAQ's

What is Shalby share price?
Can I buy Shalby shares now?
What is the Dividend Yield of Shalby?
What is the Market Cap of Shalby?
What are the key metrics to analyse Shalby?
What is the 52 Week High and Low of Shalby?
What is the trend of Shalby share price?